NYSE - Delayed Quote USD

Zoetis Inc. (ZTS)

158.42 +5.06 (+3.30%)
At close: 4:00 PM EDT
158.89 +0.47 (+0.30%)
After hours: 6:14 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Kristin C. Peck CEO & Director 3.54M 5.2M 1971
Mr. Wetteny N. Joseph Executive VP & CFO 1.6M -- 1972
Ms. Wafaa Mamilli EVP, Chief Digital & Tech. Officer, Group President for China, Brazil and Preci. Animal Health 1.36M -- 1967
Ms. Heidi C. Chen Employee Advisor 1.24M -- 1967
Dr. Robert J. Polzer Ph.D. Executive VP and President of Research & Development 1.18M 54.13k 1969
Ms. Roxanne Lagano EVP, Chief HR Officer & Global Operations, Interim General Counsel and Corporate Secretary -- -- 1965
Mr. Steven Frank Vice President of Investor Relations -- -- --
Mr. William Price VP & Chief Communications Officer -- -- --
Ms. Jeannette Ferran Astorga Executive VP of Corporate Affairs & Communications and Chief Sustainability Officer -- -- 1975
Mr. Nick Ashton Executive VP and President of Global Manufacturing & Supply -- -- 1973

Zoetis Inc.

10 Sylvan Way
Parsippany, NJ 07054
United States
973 822 7000 https://www.zoetis.com
Sector: 
Healthcare
Full Time Employees: 
14,100

Description

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Corporate Governance

Zoetis Inc.’s ISS Governance QualityScore as of April 1, 2024 is 3. The pillar scores are Audit: 5; Board: 2; Shareholder Rights: 7; Compensation: 2.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 02, 2024
Zoetis Inc. Earnings Call

Jun 04, 2024

Dividend Date

Related Tickers

ELAN Elanco Animal Health Incorporated
13.26
+1.69%
 
VTRS Viatris Inc.
11.57
+0.87%
 
TAK Takeda Pharmaceutical Company Limited
13.03
-0.31%
 
NBIX Neurocrine Biosciences, Inc.
135.99
-1.28%
 
LNTH Lantheus Holdings, Inc.
65.56
+0.55%
 
TEVA Teva Pharmaceutical Industries Limited
13.81
+4.23%
 
HLN Haleon plc
8.45
+0.60%
 
ITCI Intra-Cellular Therapies, Inc.
73.26
+1.57%
 
CGC Canopy Growth Corporation
8.91
+2.41%
 
ACB Aurora Cannabis Inc.
6.70
-0.15%